Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Assessment of the safety and efficacy of HLD-0915 (JNJ-101556143) in patients with metastatic prostate cancer who have progressed on prior systemic therapies, with further evaluation in additional prostate cancer populations.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Mężczyzna w wieku 18 lat lub starszy
- •Potwierdzony rozpoznanie raka gruczołu krokowego
- •Dobra funkcja nerek, wątroby i układu krwiotwórczego
- •Zdolność połykania tabletek
- •Poprzednie leczenie hormonalne (kastracja chirurgiczna lub terapia hormonalna)
- •Nowotwór reaguje na leczenie lub ma niski poziom testosteronu
✗ Disqualifies
- •Niedawne poważne krwawienia lub zaburzenia krzepnięcia
- •Specjalny typ raka (neuroendokrynny lub drobnokomórkowy)
- •Przyjmowanie wysokich dawek kortykosteroidów (powyżej 10 mg dziennie)
- •Wcześniejsze chemioterapie w niektórych grupach pacjentów
- •Rak tylko w węzłach chłonnych miednicy (w pewnych grupach)
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 20, 2026
- Sex
- Male only
Therapies / drugs in trial
Locations (18)
Rocky Mountain Cancer Center
Colorado Springs, United States
Sarah Cannon Research Institute 1
Denver, United States
Yale University
New Haven, United States
Florida Cancer Specialists
Sarasota, United States
XCancer Research Network LCMC Health EJGH
Metairie, United States
Dana Farber Mass General Brigham Cancer Care Inc
Boston, United States
South Texas Accelerated Research Therapeutics, LLC (START)
Grand Rapids, United States
Urology Cancer Center, PC
Omaha, United States
Memorial Sloan Kettering Cancer Center
Long Island City, United States
Associated Medical Professionals
Syracuse, United States
Duke University Medical Center
Durham, United States
Carolina Urologic Research Center
Myrtle Beach, United States
Sarah Cannon Research Institute
Nashville, United States
Urology Associates
Nashville, United States
NEXT Oncology
Austin, United States
MD Anderson Cancer Center
Houston, United States
Virginia Clinical Research
Norfolk, United States
The Royal Marsden NHS Trust
Sutton, United Kingdom
Trial contact
Study Contact
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/21/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.